Catalyze Capital is a closed-end fund investing in early-stage innovative companies throughout Europe. In line with our expertise, the fund focuses mainly on Life Science, Sustainable and Deep Tech innovations. We invest in companies that apply science and technology to make an impact in people’s and the planet’s health. Catalyze Capital invests up to € 1.5 million in small-to medium enterprises registered in Europe. We focus on companies and academic spin-offs in Seed and Series A stages, supporting them to grow and build value. We believe that innovative ideas deserve a chance to reach their full potential and become breakthrough innovations that shape the wold we live in.